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Mechanical suppression of breast cancer cell invasion and
paracrine signaling to osteoclasts requires nucleo-cytoskeletal
connectivity
Xin Yi1, Laura E. Wright 2, Gabriel M. Pagnotti2, Gunes Uzer 3, Katherine M. Powell4, Joseph M. Wallace 4,5, Uma Sankar5,
Clinton T. Rubin6, Khalid Mohammad2, Theresa A. Guise2 and William R. Thompson 1,5
Exercise benefits the musculoskeletal system and reduces the effects of cancer. The effects of exercise are multifactorial, where
metabolic changes and tissue adaptation influence outcomes. Mechanical signals, a principal component of exercise, are anabolic
to the musculoskeletal system and restrict cancer progression. We examined the mechanisms through which cancer cells sense and
respond to low-magnitude mechanical signals introduced in the form of vibration. Low-magnitude, high-frequency vibration was
applied to human breast cancer cells in the form of low-intensity vibration (LIV). LIV decreased matrix invasion and impaired
secretion of osteolytic factors PTHLH, IL-11, and RANKL. Furthermore, paracrine signals from mechanically stimulated cancer cells,
reduced osteoclast differentiation and resorptive capacity. Disconnecting the nucleus by knockdown of SUN1 and SUN2 impaired
LIV-mediated suppression of invasion and osteolytic factor secretion. LIV increased cell stiffness; an effect dependent on the LINC
complex. These data show that mechanical vibration reduces the metastatic potential of human breast cancer cells, where the
nucleus serves as a mechanosensory apparatus to alter cell structure and intercellular signaling.
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INTRODUCTION
Physical activity has beneficial consequences on nearly every
organ system. In addition to the positive effects of exercise on
cardiovascular1 and musculoskeletal health,2 regular physical
activity is associated with a reduced risk of colon, endometrial,
and breast cancers.3,4 Women who exercise, at a moderate
intensity for 3–4 h per week, have a 30%–40% reduced risk of
breast cancer, compared to sedentary women.5 In addition,
physical activity is associated with decreased cancer mortality6
and reduced tumor size in mice that ran long distances.7
Importantly, there are beneficial effects of physical activity on
cancer outcomes are realized even at low doses.8 While these
studies highlight the positive effects of exercise on cancer, the
underlying mechanisms remain largely unknown.
Physical activity inherently involves repetitive bouts of physical
movement, altering whole-body homeostasis with subsequent
adaptations at the cell, tissue, and organ levels.2 The beneficial
effects of physical activity on cancer seems, at least partially, due
to metabolic and immune effects. Physical activity results in
reduced insulin resistance and decreased hyperinsulinemia in
muscle.9 In addition, voluntary running results in reduced tumor
size in mice, due to increased recruitment and infiltration of
natural killer (NK) immune cells,7 suggesting that exercise
regulates cancer growth partially through improved immune
responses. While the effects of exercise on cancer are multi-
factorial, the contribution of mechanical force, a principal
component of physical activity, in regulating cancer progression
is unclear.
While physical activity suppresses tumor growth and reduces
cancer-related mortality, musculoskeletal complications arising
from cancer treatments and cancer itself make exercise difficult at
best, or physically dangerous at worst. The subsequent sedentary
state perpetuates bone loss, and potentially the metastatic state,10
as the mechanical forces imparted through exercise are absent.
Prior work demonstrates that the physical signals necessary to
activate cellular responses need not be large, nor of long
duration.8,11 As such, although low-intensity vibration is distinct
from the high intensity mechanical input imparted through typical
exercise regimens, introducing very low-magnitude mechanical
vibration exogenously may provide the necessary benefits of
mechanical input while avoiding the negative consequences of
more strenuous forms of traditional exercise.
Low magnitude mechanical forces can be introduced to the
musculoskeletal system through platforms that emit low-intensity
vibration (LIV) signals, serving as an effective “exercise surrogate”
by delivering mechanical input similar to that of exercise.12 LIV
promotes proliferation and differentiation of mesenchymal
progenitor cells.13 At the molecular level, LIV initiates a signaling
cascade resulting in increased phosphorylation of focal adhesion
kinase (FAK) and Akt, resulting in downstream activation of RhoA
and formation of filamentous actin structures.14 The effects of LIV
are additive, with a second bout of LIV enhancing FAK
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phosphorylation and F-actin contractility.15 The additive benefits
observed with a second bout of mechanical stimuli have also been
shown in animal16 and human studies,17 suggesting that proper
dosing primes the cells to generate a more robust response with
subsequent mechanical stimuli.
The mechanical compliance of tumor cells dictates cell
behavior, where stiffness of the plasma membrane is inversely
proportional to metastatic potential.18 Cells with decreased
stiffness display increased migration and invasion, which is
regulated by the organization of the actin cytoskeleton.19
Exogenous mechanical input enhances actin cytoskeletal struc-
ture,14 and work in non-cancerous cells demonstrates that the
nucleus serves as a critical mechanosensory organ where direct
connections between the nucleus and the cytoskeleton enable
transmission of low-magnitude vibration.15 Attachment of the
nucleus to the cytoskeleton is enabled by the LINC complex,
containing Nesprin and Sun proteins, and may be a means by
which physical activity influences the metastatic properties of
cancer cells. Further, cells from human breast tumors have
decreased expression of Nesprin and SUN,20 suggesting that the
LINC complex may regulate tumorigenicity. In this work, we
subjected human breast cancer cells to mechanical vibration and
examined direct biochemical changes of the cancer cells, indirect
paracrine signaling alterations, and the biophysical mechanisms
enabling transmission of mechanical signals to breast cancer cells.
RESULTS
LIV does not directly alter cell death but increases the
susceptibility to Fas ligand-induced apoptosis
Mechanical signals regulate cell death of several cancer types.21 To
determine if direct application of LIV to breast cancer cells
influences cell death, MDA-MB-231 human breast cancer cells
were exposed to 20-min bouts of LIV (0.3 g, 90 Hz) once- or twice-
daily for three days, in the presence or absence of TGF-β1. Control
cells were placed on the vibration platform with no LIV
transmission. Cell viability was assessed using the 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
assay. No changes in cell viability were observed with LIV or
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Fig. 1 LIV increases susceptibility of FasL-mediated apoptosis. a MTT assay demonstrated no changes in cell viability, in the presence of
absence of TGF-β1 following twice-daily LIV (2× LIV). Points represent individual measurements of biological replicates (n= 4). b Expression of
FAS was quantified by qPCR and normalized to GAPDH (n= 4). Twice-daily LIV (2× LIV) significantly increased FAS expression, no significant
difference was found with once-daily LIV (1x LIV). c qPCR analysis of CD95, normalized to GAPDH (n= 4). d Images obtained from flow
cytometry of Annexin V-stained MDA-MB-231 cells. Quadrant #3 (Q3) represents early apoptosis. e Quantification of flow cytometry data from
quadrant #3 following once- or twice-daily LIV, and treatment with PBS (veh) or recombinant Fas ligand (FASL). Data represent six independent
biological replicates. One-way ANOVA (b and c) or Two-way ANOVA (a and e) P-values: *P < 0.05, **P < 0.01
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membrane death receptor, was measured by quantitative poly-
merase chain reaction (qPCR). Once-daily LIV increased FAS
expression by twofold compared to control (no LIV), but this
change was not significant (Fig. 1b). Expression of FAS was
significantly (P < 0.05) increased by threefold, compared to
control, following twice-daily LIV (Fig. 1b). No significant
differences were observed when direct comparisons of 1× and
2× treatments were made. Expression of CD95, the gene encoding
for Fas ligand was not altered with LIV (Fig. 1c).
As twice-daily treatment with LIV-induced upregulation of FAS,
we hypothesized that expression of the Fas death receptor may
increase the susceptibility to Fas ligand-mediated apoptosis. As
such, MDA-MB-231 cells were exposed to twice-daily LIV or placed
on LIV platforms with no signal transmitted (control) and treated
with recombinant Fas ligand (75 ng·mL−1) for 24 h prior to staining
with Annexin V and subsequent sorting by flow cytometry
(Fig. 1d). No changes in apoptosis were observed following LIV
in vehicle-treated cells (Fig. 1e). Treatment with Fas ligand did not
alter apoptosis in control cells; however, addition of Fas ligand to
cells treated with LIV increased (P < 0.05) the percent of apoptotic
cells compared to control cells by ~2-fold (Fig. 1e). These data
demonstrate that application of LIV does not directly induce cell
death, but that MDA-MB-231 cells are more susceptible to Fas
ligand-mediated apoptosis following exposure to mechanical
vibration.
Low magnitude mechanical vibration suppress invasion
Extravasation and subsequent metastasis of cancer cells requires
invasion through matrix-dense borders. To determine if exogen-
ously applied LIV influenced the ability of MDA-MB-231 cells to
invade through ECM, trans-well invasion assays were performed.
Cells were treated with LIV for 20min per bout, once- or twice-
daily for three days. Cells then were trypsinized and seeded onto
trans-well membranes containing Matrigel® and visualized using
crystal violet (Fig. 2a). Once-daily LIV induced a 28.6% reduction in
invasion; however, cells exposed to LIV twice-daily had a
significant (P < 0.01) 67.1% reduction (Fig. 2b). Direct comparison
of once-daily to twice-daily LIV reveals a 54% decrease in cell
invasion with twice-daily LIV compared to the once-daily
treatment which trended toward significant (P= 0.078). The area
of cells that invaded through the trans-well membrane was also
quantified, showing a significant (P < 0.05) reduction in invasion
following twice-daily LIV, while there was no significant difference
between 1× and 2× treatments when compared directly (Fig. 2c).
As invasion through the ECM requires matrix metalloprotei-
nases (MMPs),22 MMP mRNA levels were quantified by qPCR.










































































1x LIV 2x LIVCona
e f
250 μm250 μm250 μm
b c
d
Fig. 2 LIV suppresses invasion of MDA-MB-231 cells. a Representative images showing crystal violet staining (purple) of MDA-MB-231 cells
exposed to once- (1× LIV) or twice-daily (2× LIV) LIV that have invaded through Matrigel® and penetrated through the trans-well membrane.
Images are representative of three biological replicates. b Quantification of crystal violet stained cells that invaded through the trans-well
membrane. Compared to non-vibrated controls (Con) once-daily LIV (1× LIV) induced no significant change, while twice-daily LIV (2× LIV)
resulted in a significant reduction in invasion (n= 3). c Invasion through the trans-well membrane was also quantified by measuring the total
area of crystal violet stained cells, relative to the total area of the membrane (n= 3). Similar results were found with a significant reduction in
invasion following twice-daily LIV (2× LIV). d Expression of matrix metalloproteinase 1 (MMP1) mRNA (n= 4). e Expression of MMP3 mRNA by
qPCR (n= 4). f Expression of MMP9 mRNA by qPCR (n= 4). One-way ANOVA P-values: *P < 0.05, **P < 0.01
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MMP1 expression was decreased by 75.9% (P < 0.01) following
once-daily LIV and by 66.1% (P < 0.01) with twice-daily LIV
(Fig. 2d). Expression of MMP3 was reduced by 67.9% (P < 0.05)
following once-daily LIV and by 63.5% (P < 0.05) with twice-daily
LIV (Fig. 2e). No changes in MMP9 expression were observed with
once- or twice-daily LIV (Fig. 2f).
Exposure of breast cancer cells to LIV impairs osteoclastogenesis
Breast cancer readily metastasizes to bone, resulting in osteolysis
through increased osteoclast formation.23 Tumor-mediated activa-
tion of osteoclasts results in an enhanced state of bone resorption
and release of matrix-derived growth factors, further stimulating
tumor cell invasion and growth.23 LIV restricts cancer-induced
bone loss,24,25 possibly the result of reduced secretion of pro-
osteolytic factors from the tumors themselves. To determine if direct
application of LIV to cancer cells impairs osteoclastogenesis, MDA-
MB-231 cells were exposed to LIV once- or twice-daily, as described.
Conditioned media (CM) was collected from MDA-MB-231 cultures
3 h after the last LIV treatment. Murine RAW 264.7 macrophages were
exposed to media from control or LIV-treated MDA-MB-231 cells and
stained for tartrate resistant acid phosphatase (TRAP). RAW 264.7 cells
exposed to media from control MDA-MB-231 cells readily differ-
entiated into multinucleated (>3 nuclei), TRAP positive, osteoclasts;
whereas treatment with LIV, once- or twice-daily restricted osteoclast
formation (Fig. 3a). Quantification of TRAP stained cultures
demonstrated a significant (P < 0.000 1) reduction in the number
of multinucleated cells (≥3 nuclei) following exposure of RAW
264.7 cells to CM from MDA-MB-231 cells vibrated once- (85.5%)
or twice-daily (71.2%) LIV (Fig. 3b). No changes were observed
when directly comparing 1× to 2× treatments.
To assess the activity of osteoclasts exposed to CM from MDA-
MB-231 cells, RAW 264.7 cells were seeded to osteoassay wells
(Corning, Corning NY) containing hydroxyapatite. Cells were
treated with CM from MDA-MB-231 cells exposed to once- or
twice-daily LIV. RAW 264.7 cells exposed to CM from once- and
twice-daily LIV-treated MDA-MB-231 cells reduced (P < 0.01) the
resorption pit area by 99.1% and 99.2% respectively (Fig. 3c).
These data demonstrate that mechanically stimulating MDA-MB-
231 breast cancer cells reduces their ability to support both
osteoclast formation and activity.
Osteoclast formation requires the transcription factor nuclear
factor of activated T cells 1 (NFATC1) and is accompanied by the
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Fig. 3 Mechanical stimulation of breast cancer cells releases factors that suppress osteoclastogenesis. a Representative images of murine RAW
264.7 cells stained with TRAP after addition of conditioned media from MDA-MB-231 cells not receiving LIV (CM), receiving once-daily LIV (CM
1× LIV) or twice-daily LIV (CM 2× LIV). Images are representative of four biological replicates. b Quantification of the number of osteoclasts per
area, following treatment with CM from MDA-MB-231 cells. Cells were counted as osteoclasts if they contained positive staining for TRAP
(purple) and contained ≥3 nuclei (n= 4). c RAW 264.7 cells were plated on Osteoassay wells containing hydroxyapatite and exposed to
conditioned media from MDA-MB-231 cells, as described above. The area of hydroxyapatite that was resorbed away from the dish was
quantified using ImageJ and normalized to the total area (n= 10). d Quantification of Nfatc1 mRNA from differentiated RAW 264.7 cells
following addition of CM from MDA-MB-231 cells (n= 3). Quantification of mRNA from differentiated RAW 264.7 cells following addition of CM
from MDA-MB-231 cells for genes that regulate osteoclast differentiation including d nuclear factor of activated T-cells (Nfatc1), e cathepsin-K
(Ctsk), f tartrate resistant acid phosphatase (Acp5). Data for each graph represent three biological replicates. One-way ANOVA P-values: *P <
0.05, **P < 0.01, ****P < 0.000 1
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subsequent production of genes including cathepsin K (Ctsk) and
Trap.26 To determine how CM from LIV-treated breast cancer cells
reduced osteoclast formation, RNA from RAW 264.7 cells was
examined by qPCR following exposure to CM. Exposure of RAW 264.7
cells to CM from MDA-MB-231 cells treated with once- or twice-daily
LIV reduced Nfatc1 expression by 49.6% and 44% respectively
(P< 0.05) (Fig. 3d). Expression of Ctsk was reduced (P< 0.01) in cells
treated with CM from once- (47.2%) and twice-daily (59.3%) treated
MDA-MB-231 cells (Fig. 3e). Trap (Acp5) expression was also reduced
(P< 0.05) following treatment with CM from once- and twice-daily
LIV-treated MDA-MB-231 cells, with reductions of 91.6% and 92%
respectively (Fig. 3f). These data suggest that the reductions in
osteoclast number, following exposure to CM from mechanically
stimulated breast cancer cells, are associated with suppression of
osteoclast regulatory genes, including Nfatc1, Ctsk, and Acp5.
LIV suppresses expression of factors that promote osteolysis
Within the bone microenvironment, cancer cells produce factors
that perpetuate osteoclast formation and subsequent osteolysis.
As we found that CM from human breast cancer cells, exposed to
LIV, suppressed osteoclast formation, we next sought to quantify
expression of factors produced by MDA-MB-231 cells that
promote osteolysis, following LIV. As TGF-β enhances the
metastatic phenotype of cancer cells, and increases production
of osteolytic factors,27 MDA-MB-231 were treated with TGF-β1
(5 ng·mL−1, w/v) or PBS (veh) as a control, prior to LIV. Exposure of
MDA-MB-231 cells to LIV for 20min once per day for 3 days
resulted in a 60.7% decrease of parathyroid hormone like
hormone (PTHLH) expression (P < 0.01) in the absence of TGF-β1
and a decrease of 29.7% (P < 0.05) in the presence of TGF-β1
(Fig. S1a). There were no changes in expression of connective
tissue growth factor (CTGF), CXCR4, or interleukin 11 (IL-11)
following once-daily LIV (Fig. S1b–d).
Previous work in non-tumor cells showed that twice-daily LIV
resulted in enhanced anabolic effects compared to once-daily
treatment,28 likely due to a “priming” effect following the first bout
of mechanical force. To determine if a similar priming effect occurs
in breast cancer cell expression of pro-osteolytic/metastatic genes
in MDA-MB-231 cells were also quantified following twice-daily LIV
treatment for 3 days. Treatment with LIV twice a day resulted in
reduced PTHLH expression in both the absence (83.1%, P < 0.01)
and presence (62%, P < 0.05) of TGF-β1 (Fig. 4a). LIV induced a
reduction of CTGF of 57.6% (P < 0.05) in the absence of TGF-β1;
however, no differences were found in the presence of TGF-β1
(Fig. 4b). Expression of IL-11 mRNA was reduced both in the
presence (43.3%, P < 0.01) and absence (66.9%, P < 0.05) of TGF-β1
following twice-daily LIV. Levels of C-X-C chemokine receptor type
4 (CXCR4), interleukin 8 (CXCL8), and hypoxia-inducible factor
1-alpha (HIF1A) were also quantified and no differences were
observed with LIV, regardless of the addition of TGF-β1 (Fig. 4d–f).
Osteoclast formation requires binding of receptor activator of
nuclear factor kappa-B ligand (RANKL) to the RANK receptor. While
thought to be predominantly produced by osteoblasts, RANKL is
also secreted by breast cancer cells.29–31 In contrast to RANKL,
osteoprotegerin (OPG) suppresses osteoclast formation by acting
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Fig. 4 Low-magnitude mechanical forces suppress expression of osteolytic genes. MDA-MB-231 cells were treated with PBS (Veh) or TGF-β1
and exposed to non-vibration control conditions (Con) or LIV twice-daily for 3 days. qPCR analyses were normalized to GAPDH. Genes
surveyed included a parathyroid hormone-related protein (PTHLH) (n= 3), b connective tissue growth factor (CTGF) (n= 3), c interleukin 11 (IL-
11) (n= 3), d C-X-C chemokine receptor type 4 (CXCR4) (n= 3), e interleukin 8 (CXCL8) (n= 3), f hypoxia-inducible factor 1-alpha (HIF1A) (n= 3),
g receptor activator of nuclear factor kappa-B ligand (TNFSF11, RANKL) (n= 5), and h osteoprotegerin (TNFRSF11B, OPG) (n= 5). i Quantification
of the ratio of RANKL to OPG mRNA (n= 5). Multiple t-test P-values: *P < 0.05, **P < 0.01
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twice-daily LIV reduced RANKL expression by 51.3% (P < 0.05).
When treated with TGF-β1, a non-significant increase of 3.6-fold in
RANKL was found following LIV treatment (Fig. 4g). OPG
expression was not altered with LIV in the presence or absence
of TGF-β1 (Fig. 4h); however, the ratio of RANKL to OPG expression
was reduced by 48.7% (P < 0.05) in the absence of TGF-β1 and not
significantly altered in the presence of TGF-β1 (Fig. 4i). These
results demonstrate that LIV suppresses the production of genes
in breast cancer cells that influence osteoclast formation.
Additional analyses were completed to directly compare
expression levels following once- and twice-daily LIV treatments.
Twice-daily LIV suppressed PTHLH in the presence of TGF-β1, but
no change was observed in the absence of TGF-β1 (Fig. S2a). No
changes in CTGF were observed between 1× and 2× LIV (Fig. S2b).
Twice-daily LIV suppressed CXCR4 in the presence of TGF-β1, but
no difference was observed in the absence of TGF-β1 (Fig. S2c).
Significant reductions in IL-11 expression were observed in twice-
daily treated MDA-MB-231 cells compared to once-daily, but only
in the absence of TGF-β1 (Fig. S2d). Expression of TNSF11 (RANKL)
was significantly reduced with twice-daily treatment (Fig. S2e), but
no changes were observed between 1× and 2× for TNFRSF11B
(OPG) (Fig. S2f) or for the RANKL/OPG ratio (Fig. S2g).
Low magnitude mechanical vibration increases expression of LINC
complex genes
High magnitude mechanical forces, including membrane deforma-
tion and fluid shear stress, activate intracellular signaling through
focal adhesions (FAs) at the plasma membrane.14 In contrast, low-
magnitude vibrational forces (<1 g) do not induce appreciable fluid
shear forces, nor deformation of the plasma membrane,32–34
suggesting that low-magnitude vibration signals are not transmitted
through the cell membrane. Recent work showed that the nucleus
acts as a critical mechanosensory organelle and that transmission of
low-magnitude mechanical vibration requires connections between
the nucleus and the actin cytoskeleton, which are mediated by the
LINC complex.15 To determine if LIV influenced expression of LINC
complex genes, Nesprin and Sun, MDA-MB-231 cells were treated
with recombinant TGF-β1 or PBS (veh) and subjected to LIV twice
daily for three days. Exposure to LIV, in the absence or presence of
TGF-β1 resulted in a 1.82-fold (P < 0.01) and 1.84-fold (P < 0.05)
increase in SYNE1, the gene encoding Nesprin 1, expression
respectively (Fig. 5a). SYNE2 (Nesprin 2) mRNA was increased by
2.63-fold (P < 0.05) in the absence and 1.54-fold (P < 0.01) in the
presence of TGF-β1 (Fig. 5b). The molecular weight of Nesprin1
(>1 000 kDa) presents challenges for resolving this large protein via
Western blotting, thus immunocytochemistry was performed. Cells
exposed to 3 days of twice-daily LIV had noticeably more
fluorescent labeling compared to non-vibrated cells (Fig. 5c).
Although fluorescent signal from immunocytochemistry assays is
non-stoichiometric, quantification of the fluorescent intensity
displayed a 2.4-fold increase (P < 0.01) of Nesprin1 fluorescence
signal compared to non-vibrated controls (Fig. 5c).
Transcript levels of SUN1 (Fig. 5d) and SUN2 (Fig. 5e) were
increased by ~2–4 fold following LIV both in the absence and
presence of TGFβ. Protein expression of SUN1 and SUN2 was
assessed by Western blotting. SUN1 was increased by 2.8-fold
(P < 0.01) following LIV (Fig. 5f), while SUN2 was not altered (Fig.
5g). Treatment with siRNA targeting SUN1 (Fig. 5f) or SUN2 (Fig. 5g)
knocked down each protein to nearly undetectable levels. Full
size, non-cropped blots are shown in Fig. S3. These findings
demonstrate that LIV enhances transcript expression of SYNE1,
SYNE2, SUN1, and SUN2 while increasing protein expression of
both Nesprin1 and SUN1 in human breast cancer cells.
LIV-induced suppression of osteolytic factors requires the LINC
complex
The increase in expression of LINC complex genes, following LIV,
suggested that low-magnitude mechanical forces enhance LINC
connectivity, possibly accounting for the downregulation of
factors that support osteoclast formation following LIV. As such,
MDA-MB-231 cells were transfected with a control siRNA, of similar
sequence as the targeting siRNA with variation of critical
nucleotides, or siRNA targeting both SUN1 and SUN2, to physically
disconnect the LINC complex from the actin cytoskeleton. siRNA
targeting both transcripts simultaneously was used as SUN1 and
SUN2 have redundant functions for binding actin.35 Furthermore,
while LIV resulted in increases of both SYNE and SUN genes
(Fig. 5), knockdown of SUN1/2 was chosen as the strategy to
functionally disconnect the nucleus from the cytoskeleton as
verification of knockdown is technically less challenging than
SYNE and previous work has shown that disruption of SUN is
sufficient to impair nucleocytoskeletal connectivity.35–38 Cells were
exposed to LIV twice daily for 3 days, as described. While
expression of PTHLH was significantly reduced (60%, P < 0.01) in
cells treated with a control siRNA following LIV, knockdown of
SUN1 and SUN2 (denoted as SUN1/2) resulted in the inability of LIV
to suppress PTHLH (Fig. 6a). LIV treatment resulted in no changes
in expression of CTGF with control siRNA or siRNA targeting SUN1/
2 (Fig. 6b). LIV-mediated downregulation of IL11 expression
(48.5%, P < 0.05) was mitigated following knockdown of SUN1/2
(Fig. 6c). Expression of TNSF11 (RANKL) was suppressed by LIV with
intact SUN1/2 expression (56.6%, P < 0.05) and following siRNA-
mediated SUN1/2 knockdown (73.7%, P < 0.05) (Fig. 6d). LIV had
no impact on expression of TNFRSF11B (OPG) (Fig. 6e); however,
when the RANKL/OPG ratio was evaluated, the suppression
observed with LIV treatment (54%, P < 0.05) was negated
following knockdown of SUN1/2.
MCF-7 human breast cancer cells were also subjected to LIV,
following transfection with control siRNA or siRNA targeting SUN1/
2. Similar to MDA-MB-231 cells, LIV resulted in decreased
expression of IL-11, TNSF11 and the ratio of TNSF11 to TNFRSF11B
(RANKL/OPG) (Fig. S2). Knockdown of SUN1/2 negated the ability of
LIV to suppress expression of these genes in MCF-7 cells. In control
cells (no LIV) knockdown of SUN1/2 resulted in increased CXCR4
(Fig. S4). These data demonstrate that LIV-mediated downregula-
tion of osteoclastic factors produced by breast cancer cells require
an intact LINC complex.
LIV regulates secretion of osteolytic factors from MDA-MB-231
cells
To determine if protein production and secretion of factors that
promote osteolysis are influenced by LIV, CM was collected from
MDA-MB-231 cells treated with control siRNA or siRNA targeting
SUN1/2 following 3 days of twice-daily LIV. No differences were
observed in PTHrP production following LIV with control siRNA or
SUN1/2 siRNA (Fig. S5a). Consistent with transcript levels, secretion
of IL11 was reduced following LIV (46.2%, P < 0.05), while
knockdown of SUN1/2 resulted in increased IL11 production with
LIV (2.8-fold, P < 0.05) (Fig. S5b). Secretion of RANKL was reduced
by LIV (62.1%, P < 0.5) in cells treated with control siRNA; however,
knockdown of SUN1/2 resulted in a non-significant increase in
RANKL (1.9-fold) (Fig. S5c). While there were no changes in OPG
secretion with control siRNA or siSUN1/2 (Fig. S5d), the ratio of
RANKL to OPG was decreased in cells transfected with control
siRNA (43.2%, P < 0.05) but increased (2.1-fold, P > 0.5) following
SUN1/2 knockdown (Fig. S5e). These data indicate that exposing
breast cancer cells to twice-daily LIV reduces secretion of factors
that support osteoclastogenesis, and the LINC complex is
necessary for these changes.
LIV-mediated suppression of invasion and osteoclastogenesis
requires the LINC complex
To determine if the LINC complex is necessary for the functional
effects of LIV on invasion of MDA-MB-231 cells, and the ability of
secreted factors to support osteoclast formation, SUN1/2 were
knocked down using siRNA, and cells were treated with LIV as
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described. The 66.5% reduction in invasion of MDA-MB-231 cells
through Matrigel (P < 0.05) in cells treated with a control siRNA
was negated following knockdown of SUN1/2, where no
differences in invasion were observed (Figs. 7a and S6). Similarly,
MCF-7 cells treated with LIV displayed a 41.5% reduction (P <
0.05) in invasion, while LIV had no effect following knockdown of
SUN1/2. In control cells (no LIV), knockdown of SUN1/2 resulted in
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Fig. 5 LIV upregulates production of LINC complex components. qPCR analyses of (a) nesprin 1 (SYNE1) and (b) nesprin 2 (SYNE2) mRNA from MDA-
MB-231 cells treated with PBS (Veh) or TGF-β1 and exposed to non-vibration control conditions (Con) or LIV twice-daily for 3 days. qPCR analyses were
normalized to GAPDH (n= 5). c Representative images of immunocytochemistry staining of nesprin 1 in MDA-MB-231 cells treated twice-daily with LIV
showing increased nesprin 1 signal following LIV. Images are representative of three biological replicates. qPCR analyses of (d) sun 1 (SUN1) and (e) sun 2
(SUN2) mRNA from MDA-MB-231 cells treated with PBS (Veh) or TGF-β1 and exposed to non-vibration control conditions (Con) or LIV twice-daily for
3 days. qPCR analyses were normalized to GAPDH (n= 5). Western blots of whole cell lysates (20 μg per lane) from MDA-MB-231 cells transfected with a
control siRNA (siCon) or (f) siRNA targeting SUN1 (siSUN1) or (g) siRNA targeting SUN2 and exposed to non-vibration control conditions (Con) or LIV
twice-daily for 3 days. PVDFmembranes were blotted with an antibody recognizing SUN1 and β-actin as a loading control. Densitometry was measured
using ImageJ and normalized to β-actin. Western blot images are representative of four biological replicates. Uncropped images shown in
supplementary fig. 5. Multiple t-test P-values: *P< 0.05, **P<0.01
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Osteoclast formation of RAW 264.7 macrophages was evaluated
following treatment with CM from non-vibrated and vibrated
MDA-MB-231 or MCF-7 cells. CM from LIV-treated cells resulted in
a reduction in multinucleated (>3 nuclei) osteoclasts for both
MDA-MB-231 (Figs. 7b and S8, 69.3%, P < 0.05) and MCF-7
(Fig. S7b, 16.3%, P < 0.05); whereas CM from both cell lines,
following knockdown of SUN1/2, resulted in no differences in
formation of osteoclasts.
To assess resorption activity, following exposure to CM from
MDA-MB-231 cells, RAW 264.7 macrophages were seeded on
Osteo Assay wells. Cells exposed to CM from LIV-treated MDA-MB-
231 cells, transfected with control siRNA, had a 68.7% (P < 0.05)
decrease in resorption area compared to non-vibrated controls
(Fig. 7c). In contrast, addition of CM from cells exposed to LIV, but
transfected with siRNA targeting SUN1 and SUN2, resulted in a 3.3-
fold increase in resorption (P < 0.000 1). These data demonstrate
that knockdown of Sun1 and Sun2 are essential for the ability of
LIV to regulate breast cancer cell invasion and support of
osteoclast formation and activity.
The LINC nuclear complex is required for mechanically induced
cellular stiffness
The mechanical integrity of cancer cells is inversely proportional to
metastatic potential.19 We hypothesized that the suppression of
invasion and decreases in osteoclastogenesis, observed following
LIV, may be the result of increased cell membrane stiffness. To
quantify membrane stiffness, MDA-MB-231 cells were exposed to
LIV twice-daily for 3 days, or to non-vibrated conditions. Cells were
transfected with either control siRNAs or siRNAs targeting SUN1
and SUN2, as described. Cellular stiffness (elastic modulus) was
measured by atomic force microscopy, as in Fig. 8a. In cells treated
with control siRNA, LIV increased cellular stiffness (1.2-fold,
P < 0.05), while no differences were found in cells after knockdown
of SUN1/2 (Fig. 8b).
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Fig. 6 SUN1 and SUN2 are necessary for mechanical repression of osteolytic genes. MDA-MB-231 cells were treated with control siRNA
sequences (siCon) or siRNA targeting SUN1 and SUN2 and exposed to non-vibration control conditions (Con) or LIV twice-daily for 3 days. qPCR
analyses were normalized to GAPDH. Genes surveyed included (a) PTHLH, (b) CTGF, (c) IL-11, (d) TNFSF11 (RANKL), and (e) TNFRSF11B (OPG).
i Quantification of the ratio of RANKL to OPG mRNA. All graphs represent six biological replicates (n= 6). Two-way ANOVA P-values: *P < 0.05,


















































Fig. 7 Mechanical suppression of breast cancer cell invasion and signaling to osteoclasts requires SUN1 and SUN2. a Quantification of cells
(normalized to total area) invading through trans-well membrane under control (Con, no LIV) or twice-daily LIV (LIV) conditions. Cells were
transfected with control siRNA oligos (siCon) or with siRNAs targeting both SUN1 and SUN2 (siSUN1/2). Data are representative of four
biological replicates. Representative images are shown in Supplementary Fig. 6. b Quantification of the number of osteoclasts following
exposure of RAW 264.7 cells to conditioned media from MDA-MB-231 cells that received LIV twice-daily for 3 days and transfected with control
siRNA sequences (siCon) or siRNAs targeting SUN1 and SUN2 (siSUN1/2) prior to LIV. Data were compiled from ten biological replicates and
representative images are shown in Supplementary Fig. 8. c Osteoclast resorption, as measured by the area (%) of hydroxyapatite resorbed by
differentiated RAW 264.7 cells on Osteoassay plates following the addition of conditioned media from MDA-MB-231 conditioned media. MDA-
MB-231 cells were transfected with siRNA sequences targeting SUN1 and SUN2 (siSUN1/2), as mentioned above, and exposed to twice-daily LIV,
or non-LIV control conditions (Con). Data compiled from six biological replicates and measured using ImageJ. Two-way ANOVA P-values: *P <
0.05, **P < 0.01, ***P < 0.001, ****P < 0.000 1
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As part of the LINC complex, SUN proteins enable connection
between the actin cytoskeleton and the nucleus. Low magnitude
mechanical forces enhance actin cytoskeletal structure, which may
account for the increased cellular stiffness. Exposure of MDA-MB-
231 (Fig. 8c) and MCF-7 (Fig. S9) cells to LIV twice daily for 3 days
resulted in increased actin cytoskeleton stress fiber formation, as
stained by Alexa 488-conjugated phalloidin, compared to non-
vibrated controls. The increased cytoskeletal structure observed
with LIV was negated with knockdown of SUN1/2, resulting in
phalloidin signal similar to that of non-LIV controls in both MDA-
MB-231 (Fig. 8c) and MCF-7 (Fig. S9) cells.
DISCUSSION
A variety of chemical, hormonal, and physical cues regulate cell
behavior; many of which are influenced by exercise. Mechanical
signals are a principal component of exercise and are not only
instrumental in governing adaptation of musculoskeletal tissues,
but also influence cancer cell behavior including invasion,39
division,40 migration,41 and metastasis.42 Here we demonstrate
that very low-magnitude mechanical signals, introduced in the
form of low-intensity vibration regulates invasive, apoptotic, and
osteoclastogenic properties of human breast cancer cells through
biochemical alterations of the cancer cells, via paracrine signaling
between tumor cells and osteoclasts, and via biophysical changes
in the cancer cells in response to the exogenous mechanical
vibration. Our data show that LIV directly influences human breast
cancer cells by suppressing invasion and increasing the suscept-
ibility to apoptosis. Application of mechanical vibration also
influenced paracrine signaling, resulting in suppressed osteoclast
differentiation and lytic activity. Furthermore, LIV altered the
biophysical properties of cancer cells, resulting in increased
membrane stiffness, where force transmission required connec-
tion between the nucleus and the actin cytoskeleton, mediated by
the LINC complex.
Exercise is an effective form of introducing exogenous
mechanical signals to promote musculoskeletal anabolism; 43
however, common forms of weight-bearing exercise such as
running pose challenges to cancer patients, who are already
debilitated due to their illness and subsequent treatments. This
can lead to injuries, falls, and fractures, the very thing exercise was





























































Fig. 8 Enhanced cell stiffness, induced by low-magnitude mechanical forces, requires the LINC complex. a Image showing the cantilever of
the AFM resting over the nucleus of a single MDA-MB-231 cell and representative plot showing forces generated during the approach and
retraction of the borosilicate probe (attached to the cantilever) as a function of distance. b Graph showing quantification of the elastic
modulus (E, kPa). Individual cells from three biological replicate assays were tested. The number of cells tested for each group are as follows.
Con/siCon: n= 74, LIV/siCon: n= 76, Con/siSUN1/2: n= 85, LIV/siSUN1/2: n= 85. Each data point is from AFM measurements of a single cell.
Data points from the same biological replicate are designated by color (red, white, blue). c Representative images of MDA-MB-231 cells
exposed to non-vibration control conditions (Con), twice-daily LIV, and either control siRNAs or siRNA oligos targeting SUN1 and SUN2 (siSUN1/
2). For each condition, cells were fixed following a 3-h rest period after the last LIV bout and incubated with Phalloidin-conjugated Alexa-Fluor
488 and Dapi to stain for filamentous actin (green) and nuclei (blue) respectively. Images are representative of three biological replicates.
Statistical analyses calculated using two-way ANOVA, followed by two-stage linear step-up procedure of Benjamini, Krieger, and Yekutieli to
control for false discovery rate
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input to maintain musculoskeletal health,11,44,45 yet correct dosing
is essential. In non-cancerous cells, delivery of two bouts of
mechanical input separated by a rest period of 3 h induced
greater anabolic signaling than when the mechanical stimulation
was delivered for the same overall time duration but with no rest
period.28 These findings mimic responses in mice where
incorporation of a refractory period between bouts of mechanical
stimulation diminished obesity-induced adipose accumulation.16
In this study, incorporation of a refractory period between bouts of
mechanical vibration resulted in greater effects compared to
once-daily treatment for some endpoints but not all. Twice-daily
LIV resulted in significantly decreased invasion compared to
non-vibrated cells, while there was no change compared to
controls for once-daily LIV. However, there was no direct
difference between once- and twice-daily treatments. In contrast
to the invasion assays, CM from both once- and twice-daily LIV-
treated MDA-MB-231 cells resulted in significant reductions in
osteoclast formation. In addition, qPCR analyses showed that
twice-daily LIV resulted in significantly lower expression of some
genes, including PTHLH, IL-11, and TNSF11 (RANKL) compared to
once-daily LIV; however, this was not the case for all genes
analyzed. Regulation of metastatic potential and signaling of
cancer cells to osteoclasts is complex, and likely involves the
coalescence of many signaling cascades. As such, while twice-daily
LIV is not definitively better for all assays examined, our data show
that it is more potent for some endpoints and thus may be critical
to the overall response of LIV in vitro and in vivo. A recent
randomized clinical trial in childhood cancer survivors demon-
strated that twice-daily LIV treatment, seven days per week for
one year resulted in up to 11% greater BMD.17 While the exact
pathways and dosing parameters require additional investigation,
these clinical data, along with the results from the work presented
here and other recent animal and cell46 studies provide important
insight for optimal dosing of mechanical forces in clinical settings.
Mechanical signals influence tumor cell death. In one study,
fluid shear increased apoptosis in several tumor cell types, while
no negative effects of shear were found in non-tumor cells.21 In
another study, daily application of LIV increased apoptosis of
MDA-MB-231 cells.47 We did not observe increased cell death
directly following LIV; however, LIV increased expression of the
membrane death receptor FAS, resulting in increased Fas ligand-
mediated apoptosis following LIV. As immune cells, including
natural killer (NK) cells and T cells,48 produce Fas-ligand, our data
suggest that LIV renders breast cancer cells more susceptible to
immune-mediated apoptosis. In previous work, voluntary running
decreased tumor size in mice, an effect that was linked to
increased T and NK cell tumor infiltration.7 Clearing of NK cells
from mice negated the effect of exercise.7 Our data demonstrate
that introduction of exogenous mechanical signals regulates
susceptibility of immune-mediated responses in breast cancer
cells, a possible explanation for altered tumor size following
exercise in mice.
In addition to the effects of mechanical vibration on cell
survival, we found that application of LIV reduced breast cancer
cell invasion in vitro. These changes were accompanied by
reductions in MMPs. As MMPs are associated with increased breast
cancer metastases,49,50 our data suggest that mechanical vibration
suppresses breast cancer metastasis by reducing the ability of
tumor cells to invade through matrix in vitro.
The skeleton is a frequent site of breast cancer metastasis.51
Once localized to bone, breast cancer cells release factors,
including PTHrP,52 IL-11,53 CTGF,54 and RANKL,55 which increase
osteoclast activity, leading to osteolysis and tumor progres-
sion.23,56 As such, we examined the ability of mechanical vibration
to regulate release of paracrine signals from breast cancer cells.
Here we show that direct application of LIV to human breast
cancer cells reduced expression and secretion of RANKL and IL-11.
Furthermore, when exposed to CM from LIV-treated breast cancer
cells, osteoclast precursors had reduced differentiation and
resorption activity. Previous work in murine models of ovarian
cancer24 and myeloma25 report that LIV diminished the deleter-
ious effects of cancer metastasis on bone structure, specifically by
ameliorating cancer-induced osteoclast resorption of trabecular
surfaces.25 The reduced trabecular erosion may be the result of
direct effects of LIV on osteoclasts, or through LIV-mediated
alterations in paracrine signaling of cancer cells to osteoclasts.
Data supporting the direct effects of LIV on osteoclast differentia-
tion are conflicting,57,58 where results may be influenced by the
regimen of mechanical vibration. Our data demonstrate that direct
application of LIV to breast cancer cells impairs paracrine signaling
necessary for osteoclast activation, an outcome that may be linked
to the biophysical responses of the tumor cells.
Mechanical properties of tissues influence behavior. Tumors are
stiffer than healthy tissue, due to altered matrix composition.59,60
In contrast, the plasma membrane of metastatic cells is less stiff
than non-metastatic cells.19,61,62 In addition, cell stiffness is
increased by enhanced actin cytoskeletal structure, which is
associated with decreased metastatic potential.63 Application of
mechanical force increases actin cytoskeletal structure,46 where
increased filamentous actin is frequently interpreted as enhanced
cellular stiffness. Using AFM, we found that LIV increased the
stiffness of human breast cancer cells in vitro. This effect was
negated following knockdown of SUN1/2. These results correlated
well with changes in filamentous actin where, in contrast to
control cells, LIV resulted in an increase of structured actin stress
fibers; however, these stress fibers were not seen following
knockdown of SUN1/2 and subsequent LIV. Previous work in
fibroblasts demonstrated that the stiffness of the cell membrane
was impaired following depolymerization of the actin cytoskele-
ton.64 In addition, results in mesenchymal stem cells found that
vibration signals enhanced membrane stiffness by 24% compared
to controls, which was associated with increases in signaling
pathways leading to osteogenic responses.13 Taken together, our
data suggest that application of mechanical stimuli increase cell
membrane stiffness of breast cancer cells, possibly accounting for
the decreased invasion and release of osteolytic factors. Further-
more, the LINC nuclear complex is necessary to mediate these
beneficial effects of LIV, where loss of SUN1 and SUN2 prevent the
ability of LIV to influence cell stiffness.
There were several limitations of the current study. First, the data
are from in vitro assays, thus additional work in vivo will confirm the
impact of LIV on breast cancer metastases and signaling to
osteoclasts. Second, in some assays knockdown of SUN1/2 resulted
in increased responses in non-vibrated cells, such as in the invasion
assay shown in Fig. 7a. These changes following knockdown of SUN1/
2 may have influenced the data interpretation. While the primary
focus of this work was to determine how the LINC complex regulates
the responses of cancer cells to LIV, the increase in invasion following
siSUN1/2 suggests that nucleo-cytoskeletal connectivity directly
influences metastatic properties. The influence of the LINC complex
on the metastatic potential of breast cancer cells has been suggested
in other work.20 Lastly, the majority of assays were completed with ~4
biological replicates, representing a relatively small sample size. While
our analyses demonstrate large significant differences for most assays,
a larger sample size may have captured additional differences
between samples.
These studies highlight the mechanisms through which
mechanical force, a principal component of physical exercise,
regulate the invasive potential of cancer cells and their ability to
release paracrine signals that influence cancer progression. The
role of the nucleus as a mechanosensory apparatus is just
beginning to be appreciated, as is the function of the LINC nuclear
complex in tumor pathogenicity. However, the use of exogenously
applied mechanical forces may be an addition to the therapeutic
armamentarium to both reduce tumor progression and prevent
musculoskeletal compromise.
Mechanical regulation of breast cancer cells
X Yi et al.
10
Bone Research            (2020) 8:40 
MATERIALS AND METHODS
Reagents
Fetal bovine serum (FBS) was obtained from Atlanta Biologicals
(Atlanta, GA). Culture media, trypsin-EDTA, and antibiotics were
purchased from Invitrogen (Carlsbad, CA). iTaq universal SYBR green
qPCR mastermix (cat# 172–5121) was purchased from Bio-Rad
(Hercules, CA). Recombinant human TGFβ-1 (cat# 240B002) was
purchased from R&D systems (Minneapolis, MN). Alexa 488-
conjugated phalloidin (cat# A12379) was purchased from Invitrogen.
Cells and culture conditions
Human breast cancer cell lines, MDA-MB-231, MCF-7, and RAW
264.7 cells were purchased from the American Tissue Culture
Collection (ATCC, Manassas, VA). MDA-MB-231 cells were cultured in
Dulbecco’s Modified Essential Medium (DMEM) supplemented with
FBS (10%, v/v) and penicillin/streptomycin (100 μg·mL−1). MCF-7
cells were cultured in mammary epithelial cell growth basal
medium (MEBM) supplemented with the MEGM SingleQuots™ kit
per manufacturer’s protocol. Murine RAW 264.7 macrophage cells
were cultured in DMEM containing FBS (10%, v/v), penicillin/
streptomycin (100 μg·mL−1), and recombinant RANKL (75 ng·mL−1).
Cells were seeded to densities specific to each protocol.
Real time PCR
Total RNA was isolated from cells using RNeasy kit (Qiagen,
Germantown, MD), reverse transcribed, and genes were amplified
with a BioRad CFX Connect™ qPCR machine, using gene-specific
primers, as previously described.65 PCR products were normalized to
GAPDH and quantified using the ΔΔCT method (denoted as ΔΔCq).
siRNA-mediated knockdown
MDA-MB-231 cells were transfected with gene-specific siRNA or
control siRNA (20 nmol·L−1) using PepMute Plus transfection
reagent (SignaGen Labs, Rockville, MD). After 18 h of transfection,
media was replaced with fresh DMEM containing FBS (10%, v/v)
and penicillin/streptomycin (100 μg·mL−1). LIV treatment was
initiated 1–2 h after media was replaced. The following Stealth
Select siRNAs (Invitrogen) were used in this study: negative control
for SUN1: 5′-AAGGTTGCGTGGTTATAAACGCCTG-3′; SUN1: 5′-CAGG




Antibodies targeting SUN1 (cat# ab12) and SUN2 (cat# ab124916)
were purchased from Abcam (Cambridge, MA). The Nesprin1 Ab
(cat# MA5-18077) was from Invitrogen. The anti-β actin Ab (cat#
5125) was purchased from Cell Signaling (Danvers, MA).
Low magnitude mechanical force
Low magnitude mechanical forces were applied in the form of LIV
using a custom-designed platform, as previously described.25
Individual culture dishes were placed on the vertically oscillating
platform at room temperature (RT). Cells were stimulated at a
frequency of 90 Hz at a magnitude of 0.300 g ± 0.025 g, where 1 g
is equal to the earth’s gravitational field or 9.8 m·s−2. LIV was
applied in 20-min bouts, once- or twice-daily for 3 days. Twice-
daily bouts were separated by 3 h of rest. Non-vibrated control
cells were placed on the vibration platform that was not
turned on.
Cell viability and apoptosis assays
Cell viability was assessed using the CellTiter96® Aqueous One
Solution Assay (cat# G3582), which utilizes 3-(4,5-Dimethylthiazol-
2-yl)-2,5-Diphenyltetrazolium Bromide (MTT) (Promega, Madison
WI). The assay was carried out according to the manufacturer’s
protocol. Colorimetric changes were measured at 490 nm using a
spectrophotometer. Apoptosis was quantified using the BD
Pharmingen™ (San Jose, CA) PE Annexin V detection kit (cat#
559763). Cells were stained according to the manufacturer’s
protocol and Annexin V labeled cells were quantified using a BD
Accuri C6 flow cytometry machine.
Transwell assays
Invasion of MDA-MB-231 cells was quantified using Transwell®
membrane inserts with a pore size of 8.0 μm (Corning®, Corning,
NY). Cells first were seeded to 6-well dishes, exposed to LIV or
non-LIV conditions for the appropriate number of days. At least
2 h prior to seeding of cells on to transwell inserts, Matrigel®
(Corning®, cat# 356234) was diluted with DMEM (1:5) and added
(100 μL) to the upper chamber of insert within the 24-well dish.
Following LIV, cells were trypsinized and seeded (50 000 cells per
well) onto Matrigel®-containing upper chamber of the transwell
inserts. Cells were suspended in DMEM containing FBS (1%, v/v).
The lower chamber contained DMEM with FBS (10%, v/v), P/S (1%,
v/v) and collagen (rat tail, type I, cat# 354236, 40 ng·mL−1). Cells
within the transwell insert were incubated at 37 °C for 24 h, then
fixed with methanol (100%, v/v) for 10 min and stained with
crystal violet (0.5%, w/v) for 10 min. Cell number and area were
quantified under light microscopy.
Western blotting
Whole cell lysates were prepared using radio immunoprecipitation
assay (RIPA) lysis buffer (150 mmol·L−1 NaCl, 50 mmol·L−1 Tris HCl,
1 mmol·L−1 EGTA, 0.24% sodium deoxycholate,1% Igepal, pH 7.5)
containing NaF (25 mmol·L−1) and Na3VO4 (2 mmol·L
−1). Aproti-
nin, leupeptin, pepstatin, and phenylmethylsulfonylfluoride
(PMSF) were added fresh, just prior to lysis. Whole cell lysates
(20 μg) were separated on polyacrylamide gels (4%–12%) and
transferred to polyvinylidene difluoride (PVDF) membranes.
Membranes were blocked with milk (5%, w/v) diluted in TBS-T.
Blots then were incubated overnight at 4 ˚C with the appropriate
primary antibodies. Blots were washed and incubated with
horseradish peroxidase-conjugated secondary antibody (1:5 000
dilution) (Cell Signaling) at RT for 1 h. ECL plus was used to detect
chemiluminescence (Amersham Biosciences, Piscataway, NJ).
Images were developed and acquired with an iBright CL1000
machine (Applied Biosystems), and densitometry was determined
using ImageJ software version 1.45s (NIH).
Immunofluorescence
Following LIV and/or siRNA transfection, cells were fixed with
paraformaldehyde (4%, v/v) for 20 min, permeabilized with Triton
X-100 (0.1%, v/v) for 5 min at RT, and donkey serum (5%, v/v)
blocking buffer diluted in TBS-T was added for 30 min, as
previously described.66 Cells were incubated with phalloidin-
conjugated Alexa Fluor-488 (Invitrogen) diluted in TBS (1:100)
30min at RT. Cells were washed, covered, and sealed with
mounting medium containing DAPI (Invitrogen).
Osteoclast differentiation and pit assays
Osteoclast differentiation was determined using murine RAW
264.7 macrophage cells, which were seeded onto 6-well dishes
(50 000 cells per well). Cells were maintained in DMEM containing
RANKL (75 ng·mL−1), which was replaced with CM from MDA-MB-
231 cells after 24 h. A 50% mixture of CM and DMEM was added
from each group (+/−LIV and +/−siSUN1/2) with RANKL
(75 ng·mL−1). Following 4 days of differentiation, cells were
stained with TRAP (TRAP, Sigma, Cat# 386A-1KT) according to
the manufacturer’s protocol. Cells were considered to be
osteoclasts if they stained for TRAP and had three or more nuclei.
Resorption activity of osteoclasts, in the presence of CM from
MDA-MB-231 cells, was quantified using the Osteo Assay
(Corning, Corning NY) containing hydroxyapatite. In brief,
5 000 RAW 264.7 cells were seeded onto the 96-well Osteo
Assay plate containing 200 μL of DMEM with RANKL
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(75 ng·mL−1). The next day, half the volume of media was
replaced with CM from MDA-MB-231 cells for each condition.
Media was replaced every two days. At day 4, media was
removed and 100 μL of bleach (10%, v/v) was added for 5 min at
RT. Bleach was removed and cells were washed twice with
water. Formation of pits in the hydroxyapatite were visualized
under light microscopy and quantified with ImageJ.
Determination of elastic modulus using atomic force microscopy
Cells were indented in media at RT using a BioScope Catalyst AFM
(Bruker, Santa Barbara, CA). The AFM was mounted on a Leica
DMI3000 inverted microscope (Leica Biosystems Inc., Buffalo
Grove, IL), facilitating accurate placement of the AFM probe over
individual cells. Indentations were carried out using a spherical
borosilicate bead (5 μm diameter) mounted on a gold-coated
silicon nitride cantilever (Novascan Technologies, Inc., Boone, IA).
Prior to indenting, probes were pushed onto a glass surface and
the deflection of the cantilever was used to measure the
cantilever’s deflection sensitivity (nm/V). The cantilever’s spring
constant (~0.07 N·m−1) was then determined using the thermal
tuning method. The light microscope was used to navigate to
randomly selected cells. The apex of the cantilever (where the
bead is attached) was placed directly above the nucleus, then the
AFM was engaged. A single ramp was performed using a trigger
force of 1 nN at a speed of 0.5 Hz.
Analysis was performed using Nanoscope Analysis v1.70 (Bruker).
A linear baseline correction was fit from 30% to 80% of the retraction
curve. Since Poisson’s ratio is not fully understood for cells, reduced
elastic modulus (Er) was fit for each unloading curve in a region
spanning from 20% to 75% of the maximum force using the Hertz






p  δ32: (1)
In Eq. 1, F is force exerted on the cell, r is the radius of curvature
of the probe and δ is sample deformation. Only indents with
goodness of fits (i.e., r2) >0.97 were included for analysis.
Statistical analysis
Statistical variance was expressed as the means ± standard error of
the mean (SEM). Evaluation of statistical significance performed by
one-way analysis of variance (ANOVA), two-way ANOVA, or student’s
t-test, as appropriate (Prism GraphPad, La Jolla, CA). For AFM assays,
two-way ANOVA was used followed by two-stage linear step-up
procedure of Benjamini, Krieger, and Yekutieli to control for false
discovery rate. Values were considered significant if P ≤ 0.05. All
experiments were replicated at least three times using unique
biological replicates to assure reproducibility. Biological replicates
were generated by newly passaging and seeding cells or using a
fresh aliquot of cells for each assay. Densitometry data fromWestern
blots were compiled from four biological replicates.
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